UNSPSC 85285102: Diagnosis of polyneuropathy in neoplastic disease

This classification denotes the group of activities that yields a diagnosis of Polyneuropathy in neoplastic disease. Polyneuropathy in neoplastic disease is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code G63. 1

UNSPSC 85285102 Diagnosis of polyneuropathy in neoplastic disease is a Commodity code that shows little relevant recent activity. The three most recent state and local opportunities posted under this code—a diagnostic imaging PACS system procurement from San Mateo Medical Center, a special education contracted services solicitation from Birdville Independent School District in Texas, and a temporary health professional staffing qualification vehicle from Santa Clara County Health System—do not align with the nominal scope of neurological diagnostic services for polyneuropathy in cancer patients. The San Mateo and Santa Clara opportunities involve imaging systems and temporary clinical staffing across multiple ancillary specialties (audiology, cardiology, radiology, therapy services, sterile processing), while the Birdville ISD solicitation covers school-based special education contractors including audiologists, diagnosticians, and therapists. None of these solicitations directly address polyneuropathy diagnosis or neoplastic disease-specific neurological assessment.

The mismatch between the code's stated scope and the actual opportunities posted suggests either broad UNSPSC tagging practices by these jurisdictions or limited procurement activity under this specific diagnostic code. State and local health systems and school districts in California and Texas are the issuing bodies represented in the recent record, but their posted work does not reflect demand for specialized neurological diagnostic services as the code nominally describes. Firms evaluating this code should verify directly with issuing health authorities whether polyneuropathy-related diagnostics are being procured under alternative codes or through different contracting vehicles before committing resources to pursuit.